Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$7,146,920
-$571,780 QoQ
Shares Held
9,250
-7.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
3.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$1,152,144
PutShares
1,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026DCF Advisers, LLC holds $55,922,160 across 20 Biotechnology names. REGN ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
14,650 | $10,698,162 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
637,500 | $9,326,625 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
9,250 | $7,146,920 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
160,600 | $5,140,806 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
56,000 | $4,205,040 | |
| 6 | INCY |
Incyte Corp
|
41,500 | $3,905,980 | |
| 7 | HELP |
Cybin Inc.
|
691,988 | $3,321,542 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,000 | $3,125,780 |
All Filings in REGN
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,146,920 | 9,250 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,718,700 | 10,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,622,700 | 10,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,935,000 | 9,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,644,647 | 8,900 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $6,339,737 | 8,900 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $8,147,110 | 7,750 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,930,712 | 10,400 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,202,394 | 10,600 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,715,138 | 12,200 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,152,144 | 1,400 | Put | Sole | 2023-11-13 | |
| 2023-09-30 | $8,949,690 | 10,875 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,029,684 | 11,175 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,058,911 | 11,025 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,864,241 | 10,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,612,013 | 11,050 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $354,678 | 600 | Call | Sole | 2022-08-11 | |
| 2022-06-30 | $7,507,351 | 12,700 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,095,260 | 3,000 | Put | Sole | 2022-05-13 | |
| 2022-03-31 | $10,266,774 | 14,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $126,304 | 200 | Call | Sole | 2022-02-10 | |
| 2021-12-31 | $10,862,144 | 17,200 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,682,880 | 16,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,657,370 | 15,500 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,387,390 | 13,500 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,990,564 | 12,400 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,941,272 | 12,400 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,733,260 | 12,400 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,932,723 | 12,150 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||